Literature DB >> 31932411

The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network.

Yujing J Heng1,2, Susan E Hankinson3,4, Jun Wang5, Ludmil B Alexandrov6, Christine B Ambrosone7, Victor P de Andrade8, Adam M Brufsky9, Fergus J Couch10, Tari A King11, Francesmary Modugno12, Celine M Vachon13, A Heather Eliassen4,14, Rulla M Tamimi4,14, Peter Kraft4,14.   

Abstract

BACKGROUND: The link between modifiable breast cancer risk factors and tumor genomic alterations remains largely unexplored. We evaluated the association of prediagnostic body mass index (BMI), cigarette smoking, and alcohol consumption with somatic copy number variation (SCNV), total somatic mutation burden (TSMB), seven single base substitution (SBS) signatures (SBS1, SBS2, SBS3, SBS5, SBS13, SBS29, and SBS30), and nine driver mutations (CDH1, GATA3, KMT2C, MAP2K4, MAP3K1, NCOR1, PIK3CA, RUNX1, and TP53) in a subset of The Cancer Genome Atlas (TCGA).
METHODS: Clinical and genomic data were retrieved from the TCGA database. Risk factor information was collected from four TCGA sites (n = 219 women), including BMI (1 year before diagnosis), cigarette smoking (smokers/nonsmokers), and alcohol consumption (current drinkers/nondrinkers). Multivariable regression analyses were conducted in all tumors and stratified according to estrogen receptor (ER) status.
RESULTS: Increasing BMI was associated with increasing SCNV in all women (P = 0.039) and among women with ER- tumors (P = 0.031). Smokers had higher SCNV and TSMB versus nonsmokers (P < 0.05 all women). Alcohol drinkers had higher SCNV versus nondrinkers (P < 0.05 all women and among women with ER+ tumors). SBS3 (defective homologous recombination-based repair) was exclusively found in alcohol drinkers with ER- disease. GATA3 mutation was more likely to occur in women with higher BMI. No association was significant after multiple testing correction.
CONCLUSIONS: This study provides preliminary evidence that BMI, cigarette smoking, and alcohol consumption can influence breast tumor biology, in particular, DNA alterations. IMPACT: This study demonstrates a link between modifiable breast cancer risk factors and tumor genomic alterations. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 31932411      PMCID: PMC7060119          DOI: 10.1158/1055-9965.EPI-19-1087

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  46 in total

1.  Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk.

Authors:  Wendy Y Chen; Bernard Rosner; Susan E Hankinson; Graham A Colditz; Walter C Willett
Journal:  JAMA       Date:  2011-11-02       Impact factor: 56.272

2.  Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion.

Authors:  Rulla M Tamimi; Bernard Rosner; Graham A Colditz
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

3.  In search of the tumour-suppressor functions of BRCA1 and BRCA2.

Authors:  R Scully; D M Livingston
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

Review 4.  Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012.

Authors:  Helmut K Seitz; Claudio Pelucchi; Vincenzo Bagnardi; Carlo La Vecchia
Journal:  Alcohol Alcohol       Date:  2012-03-29       Impact factor: 2.826

5.  The molecular basis of breast cancer pathological phenotypes.

Authors:  Yujing J Heng; Susan C Lester; Gary Mk Tse; Rachel E Factor; Kimberly H Allison; Laura C Collins; Yunn-Yi Chen; Kristin C Jensen; Nicole B Johnson; Jong Cheol Jeong; Rahi Punjabi; Sandra J Shin; Kamaljeet Singh; Gregor Krings; David A Eberhard; Puay Hoon Tan; Konstanty Korski; Frederic M Waldman; David A Gutman; Melinda Sanders; Jorge S Reis-Filho; Sydney R Flanagan; Deena Ma Gendoo; Gregory M Chen; Benjamin Haibe-Kains; Giovanni Ciriello; Katherine A Hoadley; Charles M Perou; Andrew H Beck
Journal:  J Pathol       Date:  2016-12-29       Impact factor: 7.996

6.  Alcohol consumption and risk of breast cancer by molecular subtype: Prospective analysis of the nurses' health study after 26 years of follow-up.

Authors:  Kelly A Hirko; Wendy Y Chen; Walter C Willett; Bernard A Rosner; Susan E Hankinson; Andrew H Beck; Rulla M Tamimi; A Heather Eliassen
Journal:  Int J Cancer       Date:  2015-10-05       Impact factor: 7.396

7.  Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.

Authors:  Kyle Ellrott; Matthew H Bailey; Gordon Saksena; Kyle R Covington; Cyriac Kandoth; Chip Stewart; Julian Hess; Singer Ma; Kami E Chiotti; Michael McLellan; Heidi J Sofia; Carolyn Hutter; Gad Getz; David Wheeler; Li Ding
Journal:  Cell Syst       Date:  2018-03-28       Impact factor: 10.304

8.  Smoking and risk of breast cancer in the Generations Study cohort.

Authors:  Michael E Jones; Minouk J Schoemaker; Lauren B Wright; Alan Ashworth; Anthony J Swerdlow
Journal:  Breast Cancer Res       Date:  2017-11-22       Impact factor: 6.466

9.  Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer.

Authors:  Bastien Nguyen; David Venet; Matteo Lambertini; Christine Desmedt; Roberto Salgado; Hugo Mark Horlings; Françoise Rothé; Christos Sotiriou
Journal:  Breast Cancer Res       Date:  2019-02-15       Impact factor: 6.466

10.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.

Authors:  Kristian Cibulskis; Michael S Lawrence; Scott L Carter; Andrey Sivachenko; David Jaffe; Carrie Sougnez; Stacey Gabriel; Matthew Meyerson; Eric S Lander; Gad Getz
Journal:  Nat Biotechnol       Date:  2013-02-10       Impact factor: 54.908

View more
  2 in total

1.  Somatic mutational profiles and germline polygenic risk scores in human cancer.

Authors:  Yuxi Liu; Alexander Gusev; Yujing J Heng; Ludmil B Alexandrov; Peter Kraft
Journal:  Genome Med       Date:  2022-02-11       Impact factor: 15.266

2.  The noncoding RNAs SNORD50A and SNORD50B-mediated TRIM21-GMPS interaction promotes the growth of p53 wild-type breast cancers by degrading p53.

Authors:  Xi Su; Chao Feng; Simeng Wang; Liang Shi; Qingqing Gu; Haihong Zhang; Xinhui Lan; Yuelei Zhao; Wei Qiang; Meiju Ji; Peng Hou
Journal:  Cell Death Differ       Date:  2021-03-19       Impact factor: 15.828

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.